Gene · 54880
Papers3,332
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
961 to 980 of 3,332
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RB1 loss triggers dependence on ESRRG in retinoblastoma. | Sci Adv | 2022 | 35984874 | PubTator, text mining | PubMed |
| Molecular classification and outcome of children with rare CNS embryonal tumors: results from St. Jude Children's Research Hospital including the multi-center SJYC07 and SJMB03 clinical trials. | Acta Neuropathol | 2022 | 35982322 | PubTator, text mining | PubMed |
| Donor-derived acute myeloid leukemia in solid organ transplantation. | Am J Transplant | 2022 | 35979657 | PubTator, text mining | PubMed |
| Phenotypically-defined stages of leukemia arrest predict main driver mutations subgroups, and outcome in acute myeloid leukemia. | Blood Cancer J | 2022 | 35973983 | PubTator, text mining | PubMed |
| Proximity labeling of endogenous RICTOR identifies mTOR complex 2 regulation by ADP ribosylation factor ARF1. | J Biol Chem | 2022 | 35973513 | PubTator, text mining | PubMed |
Towards Development of a Standard Terminology of the World Health Organization Classification of Tumors of the Central Nervous System in the Turkish Language, and a Perspective on the Practical Implications of the WHO Classification for Low and Middle Income Countries. | Turk Patoloji Derg | 2022 | 35969220 | PubTator, text mining | PubMed |
| Correlation Analysis and Prognostic Impacts of Biological Characteristics in Elderly Patients with Acute Myeloid Leukemia. | Clin Interv Aging | 2022 | 35967966 | PubTator, text mining | PubMed |
| Comprehensive characterization of clonality of driver genes revealing their clinical relevance in colorectal cancer. | J Transl Med | 2022 | 35962343 | PubTator, text mining | PubMed |
| Molecular mechanism of hyperactive tooth root formation in oculo-facio-cardio-dental syndrome. | Front Physiol | 2022 | 35957990 | PubTator, text mining | PubMed |
| Treatment of STAT5b-RARA positive acute promyelocytic leukemia by Venetoclax combining with homoharringtonine, cytarabine: A case report and literature review. | Blood Sci | 2022 | 35957665 | PubTator, text mining | PubMed |
| Increased Apoptotic Activity in Low-Risk Myelodysplastic Syndrome. | J Clin Med | 2022 | 35956220 | PubTator, text mining | PubMed |
| Histopathology and Molecular Genetics in Systemic Mastocytosis: Implications for Clinical Management. | Int J Mol Sci | 2022 | 35955907 | PubTator, text mining | PubMed |
| Substantial somatic genomic variation and selection for BCOR mutations in human induced pluripotent stem cells. | Nat Genet | 2022 | 35953586 | PubTator, text mining | PubMed |
| Prospective Clinical Genomic Profiling of Ewing Sarcoma: ERF and FGFR1 Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance. | JCO Precis Oncol | 2022 | 35952322 | PubTator, text mining | PubMed |
| Evaluation of a Patient With Non-Myoinvasive Uterine Serous Carcinoma Confined to a Polyp and Positive Peritoneal Washings With Somatic ARHGAP35 and KRAS Mutations. | Cureus | 2022 | 35949786 | PubTator, text mining | PubMed |
| Primary retroperitoneal perirenal CIC rearrangement sarcoma: A case report. | Oncol Lett | 2022 | 35949589 | PubTator, text mining | PubMed |
| Unified classification and risk-stratification in Acute Myeloid Leukemia. | Nat Commun | 2022 | 35941135 | PubTator, text mining | PubMed |
| Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance. | Am J Clin Pathol | 2022 | 35938646 | PubTator, text mining | PubMed |
| Case Report: Immune Microenvironment and Mutation Features in a Patient With Epstein-Barr Virus Positive Large B-Cell Lymphoma Secondary to Angioimmunoblastic T-Cell Lymphoma. | Front Genet | 2022 | 35938041 | PubTator, text mining | PubMed |
| Genomic Mutation Landscape of Primary Breast Lymphoma: Next-Generation Sequencing Analysis. | Dis Markers | 2022 | 35937947 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54880/papers?page=49